Edwards Lifesciences Net Income 2010-2024 | EW

Edwards Lifesciences annual/quarterly net income history and growth rate from 2010 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Edwards Lifesciences net income for the quarter ending September 30, 2024 was $3.071B, a 697.82% increase year-over-year.
  • Edwards Lifesciences net income for the twelve months ending September 30, 2024 was $4.159B, a 190.65% increase year-over-year.
  • Edwards Lifesciences annual net income for 2023 was $1.402B, a 7.85% decline from 2022.
  • Edwards Lifesciences annual net income for 2022 was $1.522B, a 1.25% increase from 2021.
  • Edwards Lifesciences annual net income for 2021 was $1.503B, a 82.55% increase from 2020.
Edwards Lifesciences Annual Net Income
(Millions of US $)
2023 $1,402
2022 $1,522
2021 $1,503
2020 $823
2019 $1,047
2018 $722
2017 $584
2016 $570
2015 $495
2014 $811
2013 $389
2012 $292
2011 $237
2010 $218
2009 $229
Edwards Lifesciences Quarterly Net Income
(Millions of US $)
2024-09-30 $3,071
2024-06-30 $366
2024-03-31 $352
2023-12-31 $370
2023-09-30 $385
2023-06-30 $307
2023-03-31 $341
2022-12-31 $398
2022-09-30 $344
2022-06-30 $406
2022-03-31 $374
2021-12-31 $335
2021-09-30 $340
2021-06-30 $490
2021-03-31 $338
2020-12-31 $310
2020-09-30 $325
2020-06-30 $-122
2020-03-31 $311
2019-12-31 $280
2019-09-30 $275
2019-06-30 $242
2019-03-31 $250
2018-12-31 $7
2018-09-30 $226
2018-06-30 $283
2018-03-31 $207
2017-12-31 $-3
2017-09-30 $170
2017-06-30 $186
2017-03-31 $230
2016-12-31 $159
2016-09-30 $141
2016-06-30 $127
2016-03-31 $143
2015-12-31 $141
2015-09-30 $118
2015-06-30 $113
2015-03-31 $123
2014-12-31 $109
2014-09-30 $95
2014-06-30 $547
2014-03-31 $60
2013-12-31 $75
2013-09-30 $77
2013-06-30 $93
2013-03-31 $144
2012-12-31 $89
2012-09-30 $69
2012-06-30 $68
2012-03-31 $65
2011-12-31 $63
2011-09-30 $52
2011-06-30 $58
2011-03-31 $64
2010-12-31 $65
2010-09-30 $48
2010-06-30 $58
2010-03-31 $48
2009-12-31 $48
2009-09-30 $74
2009-06-30 $48
2009-03-31 $61
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $43.763B $6.005B
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $202.293B 24.68
Intuitive Surgical (ISRG) United States $195.881B 102.41
Alcon (ALC) Switzerland $43.327B 28.99
IQVIA Holdings (IQV) United States $36.875B 20.32
IDEXX Laboratories (IDXX) United States $35.573B 41.89
DexCom (DXCM) United States $31.642B 47.65
Waters (WAT) United States $23.237B 34.36
STERIS (STE) Ireland $21.444B 24.69
SONOVA HOLDING (SONVY) Switzerland $20.134B 0.00
Hologic (HOLX) United States $17.445B 18.84
Fresenius Medical Care AG KGaA (FMS) Germany $13.790B 14.16
Sysmex ADR (SSMXY) Japan $13.236B 41.51
Globus Medical (GMED) United States $11.494B 29.11
Penumbra (PEN) United States $9.559B 93.64
Masimo (MASI) United States $9.193B 44.48
Teleflex (TFX) United States $8.700B 13.88
Glaukos (GKOS) United States $7.624B 0.00
PROCEPT BioRobotics (PRCT) United States $5.190B 0.00
Integer Holdings (ITGR) United States $4.713B 26.71
Veracyte (VCYT) United States $3.417B 102.54
Inari Medical (NARI) United States $3.056B 0.00
LivaNova (LIVN) United Kingdom $2.780B 16.05
TransMedics (TMDX) United States $2.423B 76.82
Nihon Kohden (NHNKY) Japan $2.410B 18.31
Elekta AB (EKTAY) Sweden $2.150B 19.33
Tandem Diabetes Care (TNDM) United States $2.120B 0.00
Integra LifeSciences Holdings (IART) United States $1.860B 9.72
RxSight (RXST) United States $1.740B 0.00
Alphatec Holdings (ATEC) United States $1.425B 0.00
Artivion (AORT) United States $1.243B 82.36
Pulse Biosciences (PLSE) United States $1.217B 0.00
OPKO Health (OPK) United States $1.065B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.878B 14.92
Paragon 28 (FNA) United States $0.830B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.716B 0.00
IRadimed (IRMD) United States $0.693B 37.48
Mesa Laboratories (MLAB) United States $0.686B 16.17
AxoGen (AXGN) United States $0.653B 0.00
OrthoPediatrics (KIDS) United States $0.591B 0.00
SiBone (SIBN) United States $0.578B 0.00
Pacific Biosciences Of California (PACB) United States $0.570B 0.00
Semler Scientific (SMLR) United States $0.525B 30.93
Treace Medical Concepts (TMCI) United States $0.502B 0.00
Tactile Systems Technology (TCMD) United States $0.456B 24.70
Delcath Systems (DCTH) United States $0.365B 0.00
CVRx (CVRX) United States $0.359B 0.00
ClearPoint Neuro (CLPT) United States $0.351B 0.00
NeuroPace (NPCE) United States $0.334B 0.00
AngioDynamics (ANGO) United States $0.290B 0.00
Inogen (INGN) United States $0.243B 0.00
Alpha Tau Medical (DRTS) Israel $0.210B 0.00
Accuray (ARAY) United States $0.204B 0.00
Sight Sciences (SGHT) United States $0.191B 0.00
KORU Medical Systems (KRMD) United States $0.181B 0.00
Nevro (NVRO) United States $0.155B 0.00
Atossa Genetics (ATOS) United States $0.147B 0.00
Sensus Healthcare (SRTS) United States $0.142B 15.16
Spectral Diagnostics (EDTXF) Canada $0.110B 0.00
Vicarious Surgical (RBOT) United States $0.097B 0.00
LENSAR (LNSR) United States $0.089B 0.00
EDAP TMS S.A (EDAP) France $0.086B 0.00
908 Devices (MASS) United States $0.086B 0.00
WORK Medical Technology Group (WOK) China $0.085B 0.00
Monogram Orthopaedics (MGRM) United States $0.081B 0.00
Covalon Technologies (CVALF) Canada $0.074B 0.00
InspireMD (NSPR) Israel $0.074B 0.00
Hyperfine (HYPR) United States $0.071B 0.00
EnVVeno Medical (NVNO) United States $0.053B 0.00
Lucid Diagnostics (LUCD) United States $0.052B 0.00
Rapid Micro Biosystems (RPID) United States $0.046B 0.00
Accelerate Diagnostics (AXDX) United States $0.043B 0.00
Envoy Medical (COCH) United States $0.043B 0.00
Spectral AI (MDAI) United States $0.040B 0.00
Neuronetics (STIM) United States $0.036B 0.00
Adagio Medical Holdings (ADGM) United States $0.033B 0.00
Precision Optics (POCI) United States $0.032B 0.00
DarioHealth (DRIO) United States $0.026B 0.00
NexGel (NXGL) United States $0.024B 0.00
Biosig Technologies (BSGM) United States $0.024B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.016B 0.00
Ekso Bionics Holdings (EKSO) United States $0.015B 0.00
Baird Medical Investment Holdings (BDMD) $0.014B 0.00
Aspira Women's Health (AWH) United States $0.014B 0.00
PAVmed (PAVM) United States $0.012B 0.00
T2 Biosystems (TTOO) United States $0.011B 0.00
QT Imaging Holdings (QTI) United States $0.011B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
Nuwellis (NUWE) United States $0.006B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00